Skip to main content

Table 2 Screening results for depressive (PHQ-9) and anxiety (GAD-7) symptoms stratified by gender and age group for different cut-offs

From: Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening

Variables

PHQ-9,

mean (SD)

PHQ-9

score ≥ 7

no (%)

PHQ-9

score ≥ 10

no (%)

GAD-7,

mean (SD)

GAD-7

score ≥ 7

no (%)

GAD-7

score ≥ 10

no (%)

total

4.6 (4.6)

270 (26.2)

147 (14.9)

4.4 (4.9)

254 (25.8)

146 (14.2)

 12–14 years

3.7 (4.3)

65 (19.3)

37 (11.0)

3.6 (3.9)

69 (19.5)

31 (8.8)

 15–17 years

4.8 (5.0)

125 (26.6)

71 (15.1)

4.4 (4.6)

138 (27.8)

73 (14.7)

 18–21 years

6.0 (5.7)

52 (34.4)

36 (23.8)

5.8 (5.5)

61 (37.7)

40 (24.7)

female

5.3 (5.3)

204 (30.2)

127 (18.8)

4.9 (4.7)

219 (30.7)

119 (16.7)

 12–14 years

4.2 (4.7)

52 (22.9)

33 (14.5)

3.9 (4.0)

51 (21.4)

22 (9.2)

 15–17 years

5.6 (5.3)

104 (32.4)

62 (19.3)

5.1 (4.7)

114 (33.5)

62 (18.2)

 18–21 years

6.8 (5.9)

47 (39.5)

32 (26.9)

6.3 (5.5)

53 (41.7)

34 (26.8)

male

3.0 (3.7)

40 (13.4)

17 (5.7)

3.1 (3.9)

50 (15.9)

26 (8.3)

 12–14 years

2.6 (2.8)

12 (11.0)

3 (2.8)

3.0 (3.6)

18 (15.8)

9 (7.9)

 15–17 years

3.3 (4.1)

21 (14.1)

9 (6.0)

3.0 (4.0)

24 (15.3)

11 (7.0)

 18–21 years

3.25 (4.0)

5 (15.6)

4 (12.5)

3.9 (4.8)

7 (20.6)

5 (14.7)

  1. PHQ-9 (score 0–27), Patient Health Questionnaire-9; GAD-7 (score 0–21), Generalized Anxiety Disorder Scale-7.